This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Accutane

Roche Holding AG

Drug Names(s): isotretinoin, Roaccutane (EU)

Description: Accutane (Isotretinoin) is a retinoid.Retinoids exert their anti-neoplastic effects by regulating the expression of genes involved in cell growth, differentiation, apoptosis, tumor-associated angiogenesis, and host immune functions. Retinoids mediate the transcription of genes through retinoid nuclear receptors. Retinoid receptors are divided into retinoid X receptors (RXRs) and retinoic acid receptors (RARs). Isotretinoin acts primarily on the RAR family of receptors.


Accutane News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug